ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis.

Omnia A Hawary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.